Quaker Houghton
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KWR research report →
Range $172 – $203
Price Chart
About the company
Quaker Chemical Corporation is a global provider of specialized chemical formulations, which it develops, produces, and markets for a broad spectrum of heavy industrial and manufacturing applications. Its global operations are strategically divided into four segments: the Americas; Europe, the Middle East, and Africa (EMEA); Asia/Pacific; and dedicated Global Specialty Businesses. The company's extensive product portfolio encompasses a wide array of offerings, including fluids for metal removal, drawing, forming, finishing, and forging, as well as cleaning solutions, corrosion inhibitors, die cast mold release agents, heat treatment and quenching compounds, hydraulic fluids, specialized greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and various surface treatment chemicals.
- CEO
- Joseph A. Berquist
- IPO
- 1980
- Employees
- 4,700
- HQ
- Conshohocken, PA, US
Get TickerSpark's AI analysis on KWR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.86B
- P/E
- 29.45
- Fwd P/E
- 21.34
- PEG
- 0.00
- P/S
- 1.45
- P/B
- 2.07
- EV/EBITDA
- 13.92
- Div Yield
- 1.23%
- Gross Margin
- 34.41%
- Op Margin
- 9.08%
- Net Margin
- 4.94%
- ROE
- 7.12%
- ROIC
- 5.57%
Latest fiscal year · YoY change
- Revenue
- $1.89B+2.7%
- Gross Profit
- $679.37M-1.0%
- Op Income
- $176.96M
- Net Income
- $-2,488,000-102.1%
- EPS
- $-0.14-102.2%
- OCF Growth
- -33.3%
- FCF Growth
- -62.7%
- 52W High
- $183.01
- 52W Low
- $112.18
- 50D MA
- $156.10
- 200D MA
- $145.17
- Beta
- 1.39
- RSI (14)
- 54
- Avg Volume
- 159.14K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Quaker Houghton posted record quarterly profitability on 10% sales growth, led by 7% volume gains and share gains across all regions, while maintaining guidance for stronger full-year EBITDA growth and gross margin recovery by year-end.· July 31, 2026
- Net sales rose 10% to $533 million, with sales volumes up 7% and adjusted EBITDA reaching a record $85 million.
- Adjusted EBITDA margin was 16%, up 40 basis points year over year and 90 basis points sequentially, while GAAP diluted EPS was $1.55 and non-GAAP diluted EPS was $2.19.
- Asia Pacific was the standout again with 12% sales growth and 10% organic volume growth; EMEA and the Americas also posted solid volume gains.
- Gross margin declined to 35.5% on higher raw material costs, but management said pricing actions and inventory timing should lift margins back above 36% by year-end.
- The company returned $33 million to shareholders in Q2, including $24 million of buybacks and $9 million of dividends, and reiterated a balanced capital allocation approach alongside M&A optionality.
Second quarter net sales were $533 million, up 10% year over year. Sales volumes increased 7%, selling price and product mix added 1%, and foreign currency added 2%. Gross margin was 35.5%, down year over year and sequentially, and adjusted EBITDA was $85 million with a 16% margin, up 40 basis points year over year. GAAP diluted EPS was $1.55 and non-GAAP diluted EPS was $2.19, up 28% year over year. Cash from operations was $29 million versus $42 million a year ago, and capex was $10 million. For the full year, management expects end markets to be flat to modestly positive in the second half of 2026, third-quarter performance to be in the range of Q2, gross margin to be around Q2 levels in Q3 and back above 36% by year-end, and meaningful revenue plus mid- to high single-digit adjusted EBITDA growth for 2026.
Joe Berquist emphasized that the quarter reflected broad-based share gains, strong execution, and resilience amid raw material inflation and Middle East-related disruption. He said demand remained steady, Asia Pacific continued to lead with double-digit volume growth, and the company’s global manufacturing network helped maintain supply continuity. He also framed the quarter as evidence that cost optimization, pricing actions, and the local-for-local model are supporting a path toward EBITDA margins above 18% over time.
Tom Coler detailed that Q2 net sales were $533 million, gross margin was 35.5%, adjusted EBITDA was $85 million, and adjusted EPS was $2.19. He said gross margin was pressured by higher raw material costs, while SG&A rose about $10 million or 8% year over year, partly offset by early transformation savings. He also noted interest expense of $10 million, a cost of debt of about 4.4% after refinancing, cash from operations of $29 million, capex of $10 million, and full-year capex expected at 2.5% to 3% of sales.
Analysts focused on raw material inflation, the sustainability of volume gains in Asia and EMEA, Americas margin pressure, pricing pass-through timing, and how management is balancing buybacks with bolt-on M&A. Management said base-oil-related inputs remain about two-thirds of the raw material basket and are still volatile, but gross margins should be roughly flat in Q3 and improve later as pricing and index adjustments flow through. On share gains, the company said its 2% to 4% target remains the right long-term range, with current outperformance driven by broad-based new wins, lower churn, and enhanced service offerings such as Fluid Intelligence. On capital allocation, management said buybacks are opportunistic rather than programmatic, with growth investments, the dividend, and M&A all competing for capital within a balanced framework.
The call showed continued execution on share gains, with 7% volume growth, record EBITDA, and strength across all three regions. Management sounded confident that pricing actions, the new China plant, transformation savings, and a strong M&A/buyback framework can support further margin and earnings growth.
Gross margin remains under pressure from elevated raw material costs, especially base oils and container costs, and management said Q3 margins may stay flat with Q2 before improving later. The Americas had lower segment earnings because of higher manufacturing and operational costs, Europe faces seasonal and demand uncertainty, and management acknowledged the Middle East situation remains volatile and hard to predict.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 77.7%
- Shares Outstanding
- 17.28M
- Float Shares
- 13.42M
of shares held by institutions
291 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for KWR, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Thom TillisSenate · NC | Sell | Feb 13, 15 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 2.11M | ▲ 86.36K |
| Vanguard Group Inc | 1.60M | ▼ 22.22K |
| Royce & Associates LP | 860.49K | ▲ 36.59K |
| Dimensional Fund Advisors LP | 776.18K | ▲ 25.39K |
| Wellington Management Group Llp | 679.62K | ▼ 68.52K |
| Vanguard Capital Management LLC | 623.89K | ▲ 151 |
| Morgan Stanley | 573.66K | ▼ 40.81K |
| State Street Corp | 571.42K | ▲ 28.56K |
| Macquarie Management Holdings, Inc. | 436.46K | ▲ 94.89K |
| William Blair Investment Management, LLC | 420.54K | ▲ 32.13K |
| Gw&K Investment Management, LLC | 392.25K | ▼ 3.72K |
| Geode Capital Management, LLC | 354.93K | ▲ 18.64K |
Held by 305 ETFs
Biggest fund positions in KWR by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 7, 26 | Bijlani Jeewat | other | 7 |
| Aug 4, 26 | Osborne William H | sell | 600 |
| Jun 15, 26 | Coler Thomas | other | 68 |
| Jun 15, 26 | Coler Thomas | other | 2,352 |
| Jun 15, 26 | Coler Thomas | other | 741 |
| Jun 15, 26 | Coler Thomas | other | 2,352 |
| Jun 15, 26 | Coler Thomas | other | 68 |
| May 31, 26 | Foufopoulos - De Ridder Lucrece | other | 18 |
| May 31, 26 | Foufopoulos - De Ridder Lucrece | other | 1,198 |
| May 31, 26 | Foufopoulos - De Ridder Lucrece | other | 365 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our KWR coverage
Recent articles, reports, and earnings notes.
No research on KWR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KWR report →Chuck Royce's Second Quarter 2026 13F: Catalyst Pharmaceuticals Reduction Leads Portfolio Shifts
gurufocus.com · Aug 14
Here's Why Quaker Chemical (KWR) is a Great Momentum Stock to Buy
zacks.com · Aug 11
Quaker Chemical's Q2 Earnings Beat, Sales Rise on Volume Growth
zacks.com · Aug 6
5 Quality Stocks Set to Reward Investors With Dividend Hikes
zacks.com · Aug 6
Quaker Chemical (KWR) International Revenue in Focus: Trends and Expectations
zacks.com · Aug 3
Quaker Houghton Q2 Earnings Call Highlights
marketbeat.com · Jul 31
Quaker Chemical Corporation (KWR) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 31
Quaker Chemical (KWR) Q2 Earnings and Revenues Surpass Estimates
zacks.com · Jul 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.